Perampanel Clinical Trials

3 actively recruiting trials across 2 locations

Also known as: Fycompa

Pipeline

Early 1: 1Phase 1: 1Phase 2: 1

Top Sponsors

Yale University1
University of California, San Francisco1
Aarhus University Hospital1

Indications

Status Epilepticus1
Heart Arrest1
Heart Disease1
Post Traumatic Stress Disorder1
Seizures1

Other1 trial

Senicapoc and Perampanel for Newly Diagnosed Glioblastoma

Early 1

San Francisco, California1 trial

PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest

Zuckerberg San Francisco General Hospital

Phase 2

New Haven, Connecticut1 trial

Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response

Yale University

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.